Advisers to the U.S. Food and Drug Administration on Tuesday backed an approval for Abbott Laboratories' (ABT.N), heart valve repair device that is designed for patients who are at risk of complications or death during surgery.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,